This is a preview of subscription content, log in via an institution to check access.
References
Boerkoel CF, Takashima H, Bacino CA, Daentl D, Lupski JR (2001) EGR2 mutation R359 W causes a spectrum of Dejerine–Sottas neuropathy. Neurogenetics 3:153–157
de Heer AM, Merchant SN, Kammeraad JA, Cruysberg JR, Huygen PL, Cremers CW (2012) Clinical follow-up and histopathology of the temporal bones in Nathalie syndrome. Audiol Neurootol 17:219–227
Dejerine J, Sottas J (1893) Sur la névrite interstitielle, hypertrophique et progressive de l’enfance. C R Soc Biol 45:63–96
Drew AP, Zhu D, Kidambi A, Ly C, Tey S, Brewer MH, Ahmad-Annuar A, Nicholson GA, Kennerson ML (2015) Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing. Mol Genet Genomic Med 3:143–154
Im SH, Kim NH (2008) First case of Madras motor neuron disease from Korea. Muscle Nerve 38:941–942
Landrieu P, Baets J, De Jonghe P (2013) Hereditary motor-sensory, motor, and sensory neuropathies in childhood. Handb Clin Neurol 113:1413–1432
Manole A, Fratta P, Houlden H (2014) Recent advances in bulbar syndromes: genetic causes and disease mechanisms. Curr Opin Neurol 27:506–514
Nalini A, Pandraud A, Mok K, Houlden H (2013) Madras motor neuron disease (MMND) is distinct from the riboflavin transporter genetic defects that cause Brown–Vialetto–Van Laere syndrome. J Neurol Sci 334:119–122
Sathasivam S (2008) Brown–Vialetto–Van Laere syndrome. Orphanet J Rare Dis 3:9
Szigeti K, Wiszniewski W, Saifi GM, Sherman DL, Sule N, Adesina AM, Mancias P, Papasozomenos S, Miller G, Keppen L, Daentl D, Brophy PJ, Lupski JR (2007) Functional, histopathologic and natural history study of neuropathy associated with EGR2 mutations. Neurogenetics 8:257–262
Timmerman V, De Jonghe P, Ceuterick C, De Vriendt E, Lofgren A, Nelis E, Warner LE, Lupski JR, Martin JJ, Van Broeckhoven C (1999) Novel missense mutation in the early growth response 2 gene associated with Dejerine–Sottas syndrome phenotype. Neurology 52:1827–1832
Warner LE, Svaren J, Milbrandt J, Lupski JR (1999) Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies. Hum Mol Genet 8:1245–1251
Johnson JO, Gibbs JR, Megarbane A, Urtizberea JA et al (2012) Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease. Brain 135(Pt 9):2875–2882. doi:10.1093/brain/aws161
Ciccolella M, Catteruccia M, Benedetti S, Moroni I, Uziel G et al (2012) Brown–Vialetto–van Laere and Fazio-Londe overlap syndromes: a clinical, biochemical and genetic study. Neuromuscul Disord 22(12):1075–1082. doi:10.1016/j.nmd.2012.05.007
Haack TB, Makowski C, Yao Y, Graf E, Hempel M, Wieland T et al (2012) Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown–Vialetto–Van Laere syndrome. J Inherit Metab Dis 35(6):943–948. doi:10.1007/s10545-012-9513-y
Acknowledgments
This work was supported by the France Génomique National infrastructure, funded as part of the “Investissements d’Avenir” program managed by the Agence Nationale pour la Recherche (contract ANR-10-INBS-09).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethical standards
The study was performed in accordance with the ethical standards statement.
Informed consent
The parents of the child signed an informed consent for the publication of the child’s photographs. All genetic tests were performed with the patients’ informed consent.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary material 1 (MP4 21987 kb)
Rights and permissions
About this article
Cite this article
Gargaun, E., Seferian, A.M., Cardas, R. et al. EGR2 mutation enhances phenotype spectrum of Dejerine–Sottas syndrome. J Neurol 263, 1456–1458 (2016). https://doi.org/10.1007/s00415-016-8153-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-016-8153-9